SUCCESSFUL TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA WITH PLASMAPHERESIS AND RITUXIMAB-A CASE SERIES
- 1 September 2021
- journal article
- Published by World Wide Journals
Abstract
Thrombotic thrombocytopenic purpura is a haematological disorder which affects the arterioles and capillaries of multiple organs.We report three cases of TTP successfully treated with plasmapheresis & low dosage rituximab.All three cases were diagnosed according to diagnostic criteria of TTP.A Weekly doses of 100 mg rituximab was given for four week(on day 1,day 8, day15 ,day22).Resolution of clinical symptoms and hemotological abnormalities after completion of treatment, all three patient achieved complete Response. The duration of complete response was 5-27 months. During the treatment course, All three patients were treated with plasmapheresis at different times, the recommended quantity of 9 plasmapheresis was 40 ml/kg once a day and the plasmapheresis was stopped when platelet dose went up to 150x10 . This case series indicates that plasmapheresis may positively support early salvage therapy in both acute/refractory and relapsing cases and its combination with rituximab exhibits short and long term favorable effects for the treatment of TTP.Keywords
This publication has 15 references indexed in Scilit:
- Thrombotic Thrombocytopenic Purpura: A Hematological EmergencyThe Journal of Emergency Medicine, 2012
- Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case reportJournal of Medical Case Reports, 2011
- A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraBlood, 2011
- Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpuraKidney International, 2009
- Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS‐13British Journal of Haematology, 2006
- Thrombotic Thrombocytopenic PurpuraThe New England Journal of Medicine, 2006
- Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)American Journal of Hematology, 2004
- Recent Advances in Thrombotic Thrombocytopenic PurpuraHematology, 2004
- Thrombotic MicroangiopathiesThe New England Journal of Medicine, 2002
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraThe New England Journal of Medicine, 1991